Literature DB >> 15061224

Cardiac toxicity during rituximab administration.

V Garypidou, V Perifanis, K Tziomalos, S Theodoridou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15061224     DOI： 10.1080/10428190310001607160

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

1.  Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma.

Authors:  Saadettin Kilickap; Bunyamin Yavuz; Sercan Aksoy; Levent Sahiner; Murat Dincer; Hakan Harputluoglu; Mustafa Erman; Kudret Aytemir; Lale Tokgozoglu; Ibrahim Barista
Journal:  Med Oncol       Date:  2008-04-15       Impact factor: 3.064

2.  Rituximab-vincristine chemotherapy-induced acute anterior wall myocardial infarction with cardiogenic shock.

Authors:  Ambuj Roy; Naveen Khanna; Nagendra Boopathy Senguttuvan
Journal:  Tex Heart Inst J       Date:  2014-02

3.  Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy.

Authors:  Wisit Cheungpasitporn; Stephen L Kopecky; Ulrich Specks; Kharmen Bharucha; Fernando C Fervenza
Journal:  J Renal Inj Prev       Date:  2016-11-02

4.  Rituximab in the treatment of pemphigus vulgaris.

Authors:  Labib R Zakka; Shawn S Shetty; A Razzaque Ahmed
Journal:  Dermatol Ther (Heidelb)       Date:  2012-11-15

5.  Rituximab-induced coronary vasospasm.

Authors:  Linda Lee; Vishal Kukreti
Journal:  Case Rep Hematol       Date:  2012-06-06

6.  "Crack lung and heart" presenting after chemotherapy in a 65-year-old man with non-Hodgkin lymphoma.

Authors:  G G Alvarez; R H C van der Jagt
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.